Assenagon Asset Management S.A. Acadia Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$13.01 - $27.22 $376,834 - $788,427	-28,965 Reduced 19.49%	119,648 $1.69 Million
Q1 2022 Apr 25, 2022	BUY	$20.94 - $27.5 $993,896 - $1.31 Million	47,464 Added 46.92%	148,613 $3.6 Million
Q4 2021 Feb 01, 2022	BUY	$16.79 - $27.09 $1.46 Million - $2.36 Million	86,934 Added 611.57%	101,149 $2.36 Million
Q3 2021 Oct 19, 2021	BUY	$15.78 - $24.77 $224,312 - $352,105	14,215 New	14,215 $236,000
Q4 2019 Jan 17, 2020	SELL	$36.21 - $51.4 $717,754 - $1.02 Million	-19,822 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$22.22 - $44.01 $440,444 - $872,366	19,822 New	19,822 $713,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.